Ask what was studied, who was studied, what was measured and whether the result applies to the exact product being sold. Evidence is useful when its boundaries are visible.
There is more than one kind of evidence
A study of an ingredient can explain why a formulator selected it. A trial of a finished formula can answer a different question about that particular product. A customer survey can describe reported satisfaction. Those sources should not be merged into one undifferentiated claim.
The AAD encourages realistic expectations and cautions that skincare claims can sound more definitive than the likely results. A cream is not a substitute for every treatment or procedure associated with younger-looking skin.[source]
Before-and-after photographs need context
A photograph can be genuine and still be difficult to interpret. Lighting, camera angle, makeup, time between images, concurrent treatment and which patients were selected can all influence the impression. A pair of photographs cannot by itself tell you the average effect or the chance of irritation.
We do not republish provider photographs as evidence that we tested a product. Nor do we present generated editorial imagery as a patient result. Images in this publication illustrate a topic; they are not clinical before-and-after records.
Read the footnote beneath the percentage
Musely’s reviewed product pages identify reported improvements as self-reported patient outcomes. Curology also labels some marketing results as self-reported. A large percentage may be interesting, but it does not automatically describe a randomized comparison or a validated clinical endpoint.[source][source]
Look for the number of participants, the question they were asked, the time point, whether people who stopped treatment were counted and whether another treatment was used. If those details are missing, the uncertainty belongs in the interpretation.
Check that the evidence matches the formulation
A study involving tretinoin does not automatically establish the benefit of every tretinoin combination. Different strengths, vehicles, supporting actives and patient groups can matter. The same caution applies when a brand presents an ingredient’s biological function as proof of a visible outcome.
FDA explains that compounded drugs are not approved finished products. A licensed prescriber, a licensed pharmacy or an active also found in an approved drug does not turn a compounded cream into an FDA-approved product.[source]
What an honest comparison can say
Our reviews can describe ingredients, published terms and practical questions. They can identify when evidence is limited. They cannot manufacture independent treatment outcomes, universal safety rankings or customer experiences we have not had.
For that reason, CoreAge Rx’s leading placement is disclosed as commercial. It is not presented as a calculated efficacy score. Alternatives remain visible, and every review explains limitations alongside potential reasons to consider the product.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- American Academy of Dermatology — How to select anti-aging skin care productsSunscreen, moisturizers, realistic expectations and label claims
- Musely — The Anti-Aging CreamProduct page; price expressed as a monthly equivalent for a two-month supply
- Curology — Custom Formula RxFormula options and consultation process
- FDA — Compounding and the FDA: Questions and AnswersCompounded drugs are not FDA-approved; oversight and evidence limitations